COMPANY PROFILE / #2541
AOA Dx
Denver, COVenture Capital-Backed
OVERVIEW
Developer of an early disease detection platform designed to revolutionize early-stage cancer detection for women. The company offers a multi-omics approach powered by glycolipids, tumor-marker gangliosides, lipids and proteins, enabling healthcare providers to deliver early cancer diagnostics and improve life-saving outcomes.
已融资40.97
最新估值65.00
员工数23
成立年份2020
公司概况
- Companies
- AOA Dx
- Description
- Developer of an early disease detection platform designed to revolutionize early-stage cancer detection for women. The company offers a multi-omics approach powered by glycolipids, tumor-marker gangliosides, lipids and proteins, enabling healthcare providers to deliver early cancer diagnostics and improve life-saving outcomes.
- Website
- www.aoadx.com
- HQ Location
- Denver, CO
- Year Founded
- 2020
- Keywords
- biomarker detection, cancer care, cancer diagnostics, detection platform, early detection cancer, gynecologic oncology, liquid biopsy platform, multi-omics platform, ovarian cancer, precision medicine, womens health
- Competitors
- InterVenn, Freenome, Nevia, Mercy BioAnalytics, Aspira Women's Health, Amadix, Nvision, GeneCker, Delfi Labs
- Ownership Status
- Privately Held (backing)
- Company Financing Status
- Venture Capital-Backed
融资与估值
- Total Raised
- 40.97
- First Financing Date
- —
- First Financing Size
- —
- First Financing Valuation
- —
- Last Financing Date
- 16-Oct-2025
- Last Financing Deal Type
- Accelerator/Incubator
- Last Financing Size
- —
- Last Financing Valuation
- —
- Last Financing Status
- Completed
- Last Known Valuation
- 65.00
- Last Known Valuation Date
- 01-Oct-2025
- Last Known Valuation Deal Type
- Later Stage VC
- Valuation Estimate
- 94.72
- Valuation Estimate Growth Rate
- 45.73%
- Active Investors
- 2468 Ventures, Adaptive Capital Partners (Singapore), AlleyCorp, Astia, Avestria Ventures, Beacon Angels, Beacon Venture Partners, Ben Littauer, Bioincubator, Biosis Ventures, CANCER FUND, Catalytic Impact Foundation, Creative Destruction Lab, Danaher Ventures, Emmeline Ventures, Endless Frontier Labs, FemHealth Ventures, Foreground Capital, Fundament, Gaingels, Good Growth Capital, Gore Range Capital, IKJ Capital, Impact Assets, Integrity Ventures (London), Joe Caruso, Joyance Partners, Juno Equity, K2X, Kaya Ventures, Keiretsu Forum, Kube VC, Labcorp Venture Fund, Launchpad Venture Group, LongeVC, Mana Ventures, Mass Innovation Network, Massachusetts Life Sciences Center, MassChallenge, MassMEDIC, NuFund Venture Group, Olive Tree Capital, Pioneer Fund, RH Capital (San Francisco), Service Provider Capital, SideCar Angels, Springboard Enterprises, Tavistock Road, TBD Angels, TCA Venture Group, Tencent Holdings, The Helm, Venture Science, Viktor Shpakovsky, VU Venture Partners, Y Combinator
- # Active Investors
- 56
- Acquirers
- —
团队与联系人
- Employees
- 23
- Employee Growth %
- 0.00%
- Employee History
- 2026: 23, 2025: 23, 2024: 23, 2023: 13, 2022: 6, 2021: 4, 2020: 2
- Primary Contact
- Oriana Papin-Zoghbi
- Primary Contact Title
- Co-Founder, Chief Executive Officer & Board Member
- Primary Contact Email
- oriana.papin@aoadx.com
- Primary Contact Phone
- +1 (787) 759-8858
增长与经营
- Revenue
- —
- Revenue Growth %
- —
- Growth Rate
- -1.30%
- Growth Rate % Change
- —
- Growth Rate Percentile
- 3
- Size Multiple
- 6.58x
- Size Multiple % Change
- 0.29%
- Size Multiple Change
- 0.02x
- Size Multiple Percentile
- 87
- Majestic Referring Domains
- 219
- SimilarWeb Unique Visitors
- 522
- SimilarWeb Unique Visitors Change
- 83
- SimilarWeb Growth Rate
- -4.66%
- SimilarWeb Growth Rate Percentile
- 3
- Success Probability Over Time – 1 Year
- 7%
- Success Probability Over Time – 3 Year
- 23%
- Success Probability Over Time – 5 Year
- 40%
记录来源：public.companies · 原始序号 #2541 · 所有字段均按数据库原值展示。